These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33834579)

  • 1. High turnover of types III and VI collagen in progressive idiopathic pulmonary fibrosis.
    Hoyer N; Jessen H; Prior TS; Sand JMB; Leeming DJ; Karsdal MA; Åttingsberg EKA; Vangsgaard GKM; Bendstrup E; Shaker SB
    Respirology; 2021 Jun; 26(6):582-589. PubMed ID: 33834579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
    Jenkins RG; Simpson JK; Saini G; Bentley JH; Russell AM; Braybrooke R; Molyneaux PL; McKeever TM; Wells AU; Flynn A; Hubbard RB; Leeming DJ; Marshall RP; Karsdal MA; Lukey PT; Maher TM
    Lancet Respir Med; 2015 Jun; 3(6):462-72. PubMed ID: 25770676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort.
    Organ LA; Duggan AR; Oballa E; Taggart SC; Simpson JK; Kang'ombe AR; Braybrooke R; Molyneaux PL; North B; Karkera Y; Leeming DJ; Karsdal MA; Nanthakumar CB; Fahy WA; Marshall RP; Jenkins RG; Maher TM
    Respir Res; 2019 Jul; 20(1):148. PubMed ID: 31299951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Biomarkers of Collagen and Elastin Turnover Are Associated With Clinically Relevant Outcomes in COPD.
    Stolz D; Leeming DJ; Kristensen JHE; Karsdal MA; Boersma W; Louis R; Milenkovic B; Kostikas K; Blasi F; Aerts J; Sand JMB; Wouters EFM; Rohde G; Prat C; Torres A; Welte T; Roth M; Papakonstantinou E; Tamm M
    Chest; 2017 Jan; 151(1):47-59. PubMed ID: 27575358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis.
    Jessen H; Hoyer N; Prior TS; Frederiksen P; Rønnow SR; Karsdal MA; Leeming DJ; Bendstrup E; Sand JMB; Shaker SB
    BMC Pulm Med; 2021 Nov; 21(1):382. PubMed ID: 34814865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis.
    Jessen H; Hoyer N; Prior TS; Frederiksen P; Karsdal MA; Leeming DJ; Bendstrup E; Sand JMB; Shaker SB
    Respir Res; 2021 Jul; 22(1):205. PubMed ID: 34261485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis.
    Hesse C; Beneke V; Konzok S; Diefenbach C; Bülow Sand JM; Rønnow SR; Karsdal MA; Jonigk D; Sewald K; Braun A; Leeming DJ; Wollin L
    Respir Res; 2022 Aug; 23(1):201. PubMed ID: 35927669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy.
    Genovese F; Boor P; Papasotiriou M; Leeming DJ; Karsdal MA; Floege J
    Nephrol Dial Transplant; 2016 Mar; 31(3):472-9. PubMed ID: 26311218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
    Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O
    RMD Open; 2024 May; 10(2):. PubMed ID: 38806188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen Type III and VI Turnover in Response to Long-Term Immobilization.
    Sun S; Henriksen K; Karsdal MA; Byrjalsen I; Rittweger J; Armbrecht G; Belavy DL; Felsenberg D; Nedergaard AF
    PLoS One; 2015; 10(12):e0144525. PubMed ID: 26641456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study.
    Juhl P; Bay-Jensen AC; Karsdal M; Siebuhr AS; Franchimont N; Chavez J
    PLoS One; 2018; 13(12):e0207324. PubMed ID: 30507931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated extracellular matrix turnover during exacerbations of COPD.
    Sand JM; Knox AJ; Lange P; Sun S; Kristensen JH; Leeming DJ; Karsdal MA; Bolton CE; Johnson SR
    Respir Res; 2015 Jun; 16(1):69. PubMed ID: 26062683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis.
    Kubo S; Siebuhr AS; Bay-Jensen AC; Juhl P; Karsdal MA; Satoh Y; Todoroki Y; Nakano K; Nakayamada S; Tanaka Y
    Int J Rheum Dis; 2020 Apr; 23(4):532-539. PubMed ID: 32022479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.
    Bihlet AR; Karsdal MA; Sand JM; Leeming DJ; Roberts M; White W; Bowler R
    Respir Res; 2017 Jan; 18(1):22. PubMed ID: 28103932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa.
    Wang S; Bager CL; Karsdal MA; Chondros D; Taverna D; Willumsen N
    J Transl Med; 2021 Jan; 19(1):39. PubMed ID: 33478521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.
    Nielsen MJ; Karsdal MA; Kazankov K; Grønbaek H; Krag A; Leeming DJ; Schuppan D; George J
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1242-1252. PubMed ID: 27696451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation.
    Fainberg HP; Moodley Y; Triguero I; Corte TJ; Sand JMB; Leeming DJ; Karsdal MA; Wells AU; Renzoni E; Mackintosh J; Tan DBA; Li R; Porte J; Braybrooke R; Saini G; Johnson SR; Wain LV; Molyneaux PL; Maher TM; Stewart ID; Jenkins RG
    Lancet Respir Med; 2024 Sep; 12(9):681-692. PubMed ID: 39025091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study.
    Dobrota R; Jordan S; Juhl P; Maurer B; Wildi L; Bay-Jensen AC; Karsdal MA; Herrick AL; Distler JHW; Allanore Y; Hoffmann-Vold AM; Siebuhr AS; Distler O
    Lancet Rheumatol; 2021 Mar; 3(3):e175-e184. PubMed ID: 38279380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort.
    Rønnow SR; Langholm LL; Karsdal MA; Manon-Jensen T; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ; Sand JMB
    Respir Res; 2020 Jul; 21(1):202. PubMed ID: 32731895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation.
    Thiele M; Johansen S; Gudmann NS; Madsen B; Kjaergaard M; Nielsen MJ; Leeming DJ; Jacobsen S; Bendtsen F; Møller S; Detlefsen S; Karsdal M; Krag A;
    Aliment Pharmacol Ther; 2021 Oct; 54(8):1070-1080. PubMed ID: 34428307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.